Search Results - "BARONCIANI, DONATELLA"

Refine Results
  1. 1
  2. 2
  3. 3

    Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation by Angelucci, Emanuele, Muretto, Pietro, Nicolucci, Antonio, Baronciani, Donatella, Erer, Buket, Gaziev, Javid, Ripalti, Marta, Sodani, Pietro, Tomassoni, Silvia, Visani, Giuseppe, Lucarelli, Guido

    Published in Blood (01-07-2002)
    “…To identify the role of iron overload in the natural history of liver fibrosis, we reviewed serial hepatic biopsy specimens taken annually from patients cured…”
    Get full text
    Journal Article
  4. 4

    Hepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major by Angelucci, Emanuele, Brittenham, Gary M, McLaren, Christine E, Ripalti, Marta, Baronciani, Donatella, Giardini, Claudio, Galimberti, Maria, Polchi, Paola, Lucarelli, Guido

    Published in The New England journal of medicine (03-08-2000)
    “…Quantitative studies of iron balance in patients with thalassemia major have been limited by the lack of a method for determining the total amount of stored…”
    Get full text
    Journal Article
  5. 5

    Selecting β‐thalassemia Patients for Gene Therapy: A Decision‐making Algorithm by Baronciani, Donatella, Casale, Maddalena, De Franceschi, Lucia, Graziadei, Giovanna, Longo, Filomena, Origa, Raffaella, Rigano, Paolo, Pinto, Valeria, Marchetti, Monia, Gigante, Antonia, Iolascon, Achille, Forni, Gian Luca

    Published in HemaSphere (01-05-2021)
    “…This expert opinion originally developed by a panel of the Italian Society of Thalassemias and Hemoglobinopathies (SITE), reviewed and adopted by the European…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm by Baronciani, Donatella, Casale, Maddalena, De Franceschi, Lucia, Graziadei, Giovanna, Longo, Filomena, Origa, Raffaella, Pinto, Valeria Maria, Rigano, Paolo, Marchetti, Monia, Gigante, Antonia, Angelucci, Emanuele, Cappellini, Maria Domenica, Iolascon, Achille, Piga, Antonio, Forni, Gian Luca

    Published in Blood (13-11-2019)
    “…Introduction and Aim Till today, the only curative and most widely used therapy for β-thalassemia (β-TDT) is allogeneic HSCT: the European Society for Bone…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Reproducibility of liver iron concentration measured on a biopsy sample: A validation study in vivo by Urru, Silvana Anna Maria, Tandurella, Igor, Capasso, Mario, Usala, Emilio, Baronciani, Donatella, Giardini, Claudio, Visani, Giuseppe, Angelucci, Emanuele

    Published in American journal of hematology (01-02-2015)
    “…Determination of liver iron concentration is essential to predict iron related tissue damage and to guide chelation therapy. To assess the reliability of a…”
    Get full text
    Journal Article
  12. 12

    Autologous Stem Cell Transplantation in Acute Myeloid Leukemia; A Single Centre “Real Life” Study by Baronciani, Donatella, Depau, Cristina, Targhetta, Clara, Usai, Sara Veronica, Di Tucci, Anna Angela, Romani, Claudio, Tandurella, Igor, Angelucci, Emanuele

    Published in Blood (06-12-2014)
    “…Background. Autologous stem cell transplant is a consolidation treatment for standard risk acute myeloid leukemia (AML). Traditional preparative regimens, most…”
    Get full text
    Journal Article
  13. 13

    Once Daily Intravenous Busulphan Plus Fludarabine As New Reduced Toxicity Myeloablative Conditioning for Acute Myeloid Leukemia and MDS Allogeneic Transplantation by Baronciani, Donatella, Depau, Cristina, Targhetta, Clara, Di Tucci, Anna Angela, Derudas, Daniele, Culurgioni, Fabio, Pulisci, Donatella, Tandurella, Igor, Angelucci, Emanuele

    Published in Blood (06-12-2014)
    “…▪ Background. Allogeneic hemopoietic stem cell transplantation is the treatment of choice for high and intermediate risk acute myeloid leukemia (AML) and for…”
    Get full text
    Journal Article
  14. 14
  15. 15

    New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years by Sodani, Pietro, Gaziev, David, Polchi, Paola, Erer, Buket, Giardini, Claudio, Angelucci, Emanuele, Baronciani, Donatella, Andreani, Marco, Manna, Marisa, Nesci, Sonia, Lucarelli, Barbarella, Clift, Reginald A., Lucarelli, Guido

    Published in Blood (15-08-2004)
    “…When prepared for transplantation with busulfan (BU) 14 mg/kg and cyclophosphamide (CY) 120 to 160 mg/kg, patients with thalassemia in risk class 3, aged…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Safety, Feasibility and Cost Of Hematopoietic Stem Cell Transplantation Management By Peripheral Inserted Central Catheter (PICC): A Phase II Prospective Study by Derudas, Daniele, Baronciani, Donatella, Depau, Cristina, Pilo, Federica, Targhetta, Clara, Usai, Sara Veronica, Longhitano, Giuseppe, Ibba, Daniela, Angelucci, Emanuele

    Published in Blood (15-11-2013)
    “…The management of high dose chemotherapy followed by autologous or allogeneic hemopoietic stem cell transplantation requires an intravenous line for…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Hematopoietic Stem Cell Transplantation in Thalassemia Major. Report from the EBMT Hemoglobinopathy Registry by Baronciani, Donatella, Pilo, Federica, Lyon-Caen, Sarah, Poetschger, Ulrike, Dini, Giorgio, Peters, Christina

    Published in Blood (18-11-2011)
    “…Abstract 905 Hemopoietic allogeneic stem cell transplantation (HSCT) still remains the only available curative option for β-thalassaemia major. At today more…”
    Get full text
    Journal Article